Chia-Hsien Cheng
Papers
1
Total Citations
7
H-Index
1
About
Chia-Hsien Cheng is a leading clinical researcher in urologic oncology, with a focused expertise in the management of locally advanced prostate cancer. His most impactful work employs rigorous statistical methods, such as propensity score matching, to compare the effectiveness of radical prostatectomy versus radiotherapy combined with androgen deprivation therapy. In a landmark 2022 study, Cheng analyzed outcomes from 315 patients with clinical T3/T4 disease, providing critical evidence that helps guide treatment decisions for this challenging patient population. His research directly addresses a major clinical dilemma—whether surgery or radiation offers superior oncologic control and quality of life—and has garnered early attention with 7 citations. By leveraging real-world data and advanced biostatistics, Cheng contributes to personalized treatment strategies in prostate cancer, bridging the gap between surgical and radiation oncology. His work is particularly valuable for clinicians and researchers seeking to optimize multimodal therapy in locally advanced disease, and his ongoing investigations continue to shape evidence-based practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1